Determination of selective and nonselective compounds for the 5-HT(1A) and 5-HT(1B) receptor subtypes in rat frontal cortex

M. A. Sills, B. B. Wolfe, Alan Frazer

Research output: Contribution to journalArticle

304 Citations (Scopus)

Abstract

Recent studies indicate that there are multiple subtypes of the 5-hydroxytryptamine1 (5-HT1) receptor. Previously, we provided evidence consistent with the finding that multiple states of the 5-HT1 receptor are present when the binding of [3H]-5-HT is measured in the absence of guanine nucleotides. When 1 mM GTP was present in the [3H]5-HT receptor binding assay, the high affinity state was eliminated. As the presence of multiple states of a receptor complicates the interpretation of the inhibition of [3]-5-HT binding caused by serotonin agonists and antagonists, we examined the ability of a series of these drugs to compete for 15 nM [3H]-5-HT binding in the presence of 1 mM GTP in the rat frontal cortex. Eight agonists and five antagonists showed selectivity for the two subtypes of the 5-HT1 receptor, whereas three agonists and four antagonists showed the same affinity for these two receptors subtypes. Most of the compounds examined exhibited only a modest 10- to 30 fold degree of selectivity. However, 1-(m-trifluoromethylphenyl) piperazine and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole were about 65-fold selective and spiperone was over 100-fold selective for one of the receptor subtypes. The subtype specificity of the selective compounds was determined using either spiperone, a selective 5-HT1A) compound, or 1-(m-trifluoromethylphenyl)piperazine, a selective 5-HT(1B) compound, to preferentially inhibit one of the receptors. The results of these experiments indicate that spiperone, pizotifen and the indole agonists 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine are selective for the 5-HT(1A) receptor, whereas 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole and the piperazine agonists 1-(m-trifluoromethylphenyl)piperazine, 1-(m-chlorophenyl)piperazine and quipazine are selective for the 5-HT(1B) receptor. No antagonists selective for the 5-HT(1B) subtype were identified. These results indicate that selective indole agonists show a higher affinity for the 5-HT(1A) receptor and piperazine agonists demonstrate selectivity for the 5-HT(1B) receptor. Also, the data are consistent with there being only two subtypes of the 5-HT1 receptor in rat frontal cortex.

Original languageEnglish (US)
Pages (from-to)480-487
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume231
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT1B
Frontal Lobe
Spiperone
Serotonin
Serotonin Antagonists
Receptor, Serotonin, 5-HT1A
Guanosine Triphosphate
Pizotyline
N,N-Dimethyltryptamine
Methoxydimethyltryptamines
Quipazine
Serotonin Receptor Agonists
Guanine Nucleotides
Serotonin Receptors
indole
Pharmaceutical Preparations
1-(3-trifluoromethylphenyl)piperazine
piperazine

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{b6489ef4d18b42c38245f11207286faa,
title = "Determination of selective and nonselective compounds for the 5-HT(1A) and 5-HT(1B) receptor subtypes in rat frontal cortex",
abstract = "Recent studies indicate that there are multiple subtypes of the 5-hydroxytryptamine1 (5-HT1) receptor. Previously, we provided evidence consistent with the finding that multiple states of the 5-HT1 receptor are present when the binding of [3H]-5-HT is measured in the absence of guanine nucleotides. When 1 mM GTP was present in the [3H]5-HT receptor binding assay, the high affinity state was eliminated. As the presence of multiple states of a receptor complicates the interpretation of the inhibition of [3]-5-HT binding caused by serotonin agonists and antagonists, we examined the ability of a series of these drugs to compete for 15 nM [3H]-5-HT binding in the presence of 1 mM GTP in the rat frontal cortex. Eight agonists and five antagonists showed selectivity for the two subtypes of the 5-HT1 receptor, whereas three agonists and four antagonists showed the same affinity for these two receptors subtypes. Most of the compounds examined exhibited only a modest 10- to 30 fold degree of selectivity. However, 1-(m-trifluoromethylphenyl) piperazine and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole were about 65-fold selective and spiperone was over 100-fold selective for one of the receptor subtypes. The subtype specificity of the selective compounds was determined using either spiperone, a selective 5-HT1A) compound, or 1-(m-trifluoromethylphenyl)piperazine, a selective 5-HT(1B) compound, to preferentially inhibit one of the receptors. The results of these experiments indicate that spiperone, pizotifen and the indole agonists 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine are selective for the 5-HT(1A) receptor, whereas 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole and the piperazine agonists 1-(m-trifluoromethylphenyl)piperazine, 1-(m-chlorophenyl)piperazine and quipazine are selective for the 5-HT(1B) receptor. No antagonists selective for the 5-HT(1B) subtype were identified. These results indicate that selective indole agonists show a higher affinity for the 5-HT(1A) receptor and piperazine agonists demonstrate selectivity for the 5-HT(1B) receptor. Also, the data are consistent with there being only two subtypes of the 5-HT1 receptor in rat frontal cortex.",
author = "Sills, {M. A.} and Wolfe, {B. B.} and Alan Frazer",
year = "1984",
language = "English (US)",
volume = "231",
pages = "480--487",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Determination of selective and nonselective compounds for the 5-HT(1A) and 5-HT(1B) receptor subtypes in rat frontal cortex

AU - Sills, M. A.

AU - Wolfe, B. B.

AU - Frazer, Alan

PY - 1984

Y1 - 1984

N2 - Recent studies indicate that there are multiple subtypes of the 5-hydroxytryptamine1 (5-HT1) receptor. Previously, we provided evidence consistent with the finding that multiple states of the 5-HT1 receptor are present when the binding of [3H]-5-HT is measured in the absence of guanine nucleotides. When 1 mM GTP was present in the [3H]5-HT receptor binding assay, the high affinity state was eliminated. As the presence of multiple states of a receptor complicates the interpretation of the inhibition of [3]-5-HT binding caused by serotonin agonists and antagonists, we examined the ability of a series of these drugs to compete for 15 nM [3H]-5-HT binding in the presence of 1 mM GTP in the rat frontal cortex. Eight agonists and five antagonists showed selectivity for the two subtypes of the 5-HT1 receptor, whereas three agonists and four antagonists showed the same affinity for these two receptors subtypes. Most of the compounds examined exhibited only a modest 10- to 30 fold degree of selectivity. However, 1-(m-trifluoromethylphenyl) piperazine and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole were about 65-fold selective and spiperone was over 100-fold selective for one of the receptor subtypes. The subtype specificity of the selective compounds was determined using either spiperone, a selective 5-HT1A) compound, or 1-(m-trifluoromethylphenyl)piperazine, a selective 5-HT(1B) compound, to preferentially inhibit one of the receptors. The results of these experiments indicate that spiperone, pizotifen and the indole agonists 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine are selective for the 5-HT(1A) receptor, whereas 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole and the piperazine agonists 1-(m-trifluoromethylphenyl)piperazine, 1-(m-chlorophenyl)piperazine and quipazine are selective for the 5-HT(1B) receptor. No antagonists selective for the 5-HT(1B) subtype were identified. These results indicate that selective indole agonists show a higher affinity for the 5-HT(1A) receptor and piperazine agonists demonstrate selectivity for the 5-HT(1B) receptor. Also, the data are consistent with there being only two subtypes of the 5-HT1 receptor in rat frontal cortex.

AB - Recent studies indicate that there are multiple subtypes of the 5-hydroxytryptamine1 (5-HT1) receptor. Previously, we provided evidence consistent with the finding that multiple states of the 5-HT1 receptor are present when the binding of [3H]-5-HT is measured in the absence of guanine nucleotides. When 1 mM GTP was present in the [3H]5-HT receptor binding assay, the high affinity state was eliminated. As the presence of multiple states of a receptor complicates the interpretation of the inhibition of [3]-5-HT binding caused by serotonin agonists and antagonists, we examined the ability of a series of these drugs to compete for 15 nM [3H]-5-HT binding in the presence of 1 mM GTP in the rat frontal cortex. Eight agonists and five antagonists showed selectivity for the two subtypes of the 5-HT1 receptor, whereas three agonists and four antagonists showed the same affinity for these two receptors subtypes. Most of the compounds examined exhibited only a modest 10- to 30 fold degree of selectivity. However, 1-(m-trifluoromethylphenyl) piperazine and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole were about 65-fold selective and spiperone was over 100-fold selective for one of the receptor subtypes. The subtype specificity of the selective compounds was determined using either spiperone, a selective 5-HT1A) compound, or 1-(m-trifluoromethylphenyl)piperazine, a selective 5-HT(1B) compound, to preferentially inhibit one of the receptors. The results of these experiments indicate that spiperone, pizotifen and the indole agonists 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine are selective for the 5-HT(1A) receptor, whereas 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)indole and the piperazine agonists 1-(m-trifluoromethylphenyl)piperazine, 1-(m-chlorophenyl)piperazine and quipazine are selective for the 5-HT(1B) receptor. No antagonists selective for the 5-HT(1B) subtype were identified. These results indicate that selective indole agonists show a higher affinity for the 5-HT(1A) receptor and piperazine agonists demonstrate selectivity for the 5-HT(1B) receptor. Also, the data are consistent with there being only two subtypes of the 5-HT1 receptor in rat frontal cortex.

UR - http://www.scopus.com/inward/record.url?scp=0021713455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021713455&partnerID=8YFLogxK

M3 - Article

C2 - 6502510

AN - SCOPUS:0021713455

VL - 231

SP - 480

EP - 487

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -